Background
Hepatitis B virus (HBV) is the prototype of
hepadnaviridae. It is estimated that around 350 million people are carriers of hepatitis B surface antigen (HBsAg) worldwide [
1,
2]. Persistent HBV infection leads to chronic hepatitis, and is closely associated with the development of liver cirrhosis and hepatocellular carcinoma (HCC) [
3]. Three forms of viral particles can be detected in the serum of HBV infected patients, namely, 42 nm diameter mature virion particles, 22 nm diameter spherical particles and 22 nm diameter filamentous particles [
4]. Uniquely, 22 nm subviral particles, which are composed of HBsAg and do not contain viral DNA, usually outnumber the virions in patient serum by a factor of 1000-fold or more [
5]. Though HBsAg has been identified as the neutralizing antigen of HBV and has been used as the major component of preventive vaccine for viral hepatitis B, persistence of HBsAg in serum of patients has been recognized as a high risk factor for development of HCC [
6,
7]. The possible roles of HBV envelope proteins LHBs (Pre-S1/Pre-S2/S) and MHBs (Pre-S2/S) in HCC development have been reported [
8,
9]. However, the role of major HBsAg in tumorigenesis has not been studied in detail.
By microarray study of cells transfected with the S gene coding for HBsAg, we have previously shown that marked up-regulation of lymphoid enhancer-binding factor 1 (LEF-1), a transcriptional factor in
Wnt pathway, was closely correlated with HBsAg expression [
10]. Furthermore, the expression level and cellular distribution of LEF-1 protein, mainly the dominant negative truncated isoform, was changed by the expression of HBsAg. In this study, we aimed to investigate the roles played by HBsAg on LEF-1 expression in the development of HBV-associated HCC. By immunohistochemical analysis and molecular studies, the intracellular expression and distribution of LEF-1 and HBsAg,
cyclin D1 and
c-myc gene expression were compared between HBsAg positive and negative HCC tissues, peritumor tissues and normal liver tissues. The possible roles of HBsAg in HCC development are discussed.
Discussion
Hepatocellular carcinoma is the fifth most common malignancy worldwide [
13]. Its risk factors include chronic infections by hepatitis B and C virus (HBV and HCV), and nonviral liver diseases [
14,
15]. Epidemiological study indicated that long term persistence of HBsAg in chronic hepatitis B patients is a risk factor for the development of HCC [
7]. Extensive studies have been carried out to reveal the roles of HBV in contributing to proliferation and anti-apoptotic behavior of HCC cells [
16,
17]. Cumulative data suggested that HBx is a multifunctional regulatory viral protein, which interferes directly or indirectly with a variety of cellular functions including cell cycle progression, transformation and apoptosis [
18‐
20]. Other groups reported that LHBs and MHBs functioned as trans-activators which induced cell proliferation and/or cell death of hepatocytes [
21‐
23]. In this study we investigated the possible roles played by major HBs in tumorgenesis, and the association between HBsAg expression and
Wnt signaling pathway deregulation in HBV-associated HCC tissues.
To reveal the implications of
in vivo association between HBsAg and LEF-1 up-regulation in HCC, the expression levels of these two proteins were compared both by immunohistochemical staining and by real-time PCR among HCC tumor tissues, peritumor tissues and normal liver tissues. Experimental data have shown that the aberrant regulation of the canonical
Wnt pathway was one of the important events involved in HCC development [
24,
25]. However, mutations in β-catenin or adenomatous polyposis coli (APC) genes, which appeared in over 90% of colorectal cancers [
26,
27] were found only in about 20–30% of HCCs [
28], suggesting that the predominant mechanisms activating
Wnt signaling pathway in HCCs could be different from that in other cancers. Bengochea et al reported that deregulation of Wnt/Frizzled receptor elements was common in human hepatocellular carcinoma [
29], and disturbance of regulatory mechanisms other than mutations involving β-catenin is more likely of importance in HCC. Our results on the molecular expression levels among 30 HCC tissue and 9 normal liver tissues showed that HBsAg up-regulated not only LEF-1 but also the two of LEF-1 downstream genes expression levels. These finding provided evidence that HBsAg affected the
Wnt pathway via up-regulation of LEF-1.
In this study, though all 30 HCC samples were collected from serum HBsAg positive patients, only 13 liver tissues were HBsAg positive by immunohistochemical staining. Since the expression pattern of LEF-1 was not significnatly changed in HBsAg negative HCC tissues, to reveal the roles of HBsAg on HCC development, we concentrated on these 13 pairs of HBsAg positive samples. Specifically, the expression levels of HBsAg, LEF-1,
cyclin D1 and
c-myc were studied in tumor cells and peritumor cells from the same patient. LEF-1 expression levels were found associated with the levels of HBsAg expression in HCC tissues. Interestingly, the intracellular distribution of LEF-1 protein in tumor cells was different from that in peritumor cells. In the peritumor cells LEF-1 was predominantly located in the cytoplasm, while in the tumor cells LEF-1 was located exclusively in the nucleus or both in the nucleus and cytoplasm. This observation is in accordance with a recent report stating that LEF-1/TCF was up-regulated in 52% of HCCs by strong nuclear LEF-1/TCF staining [
30]. As we have previously observed that expression of HBsAg initiated transfer of LEF-1 from the cytoplasm into the nucleus, in this study, we further identified that the transfer of LEF-1 into the nucleus also occurred in tumor cells. The different distribution of LEF-1 in tumor cells and peritumor cells suggests that different mechanisms could be involved in the pre-malignant stage and the malignant stage in HBV associated HCC.
Our previous study showed that the 38 kDa truncated isoform of LEF-1 was markedly induced in HBsAg expressing cells, while full-length LEF-1 did not show a significant change. It was reported that the 55 kDa full-length LEF-1 contains three functional domains, namely, β-catenin binding domain, context-dependent activation domain (CAD) and HMG DNA binding domain, while the 38 kDa truncated isoform of LEF-1 which lacks the β-catanin binding domain derived from an intronic promoter and exhibits dominant negative activity [
31,
32]. To further investigate the expression of LEF-1 isoforms in HCCs, quantitative real-time PCR was employed to analyze the expression patterns of LEF-1 isoforms in 30 pairs of HCC tissues in tumor cells and peritumor cells. Compared to those in normal liver tissues, though both isoforms were significantly up-regulated in HCC, the 38 kDa truncated isoform of LEF-1 was more significantly up-regulated in tumor cells, than that in peritumor cells especially in those 13 HBsAg positive HCC tissues. The 55 kDa full-length LEF-1 showed no changes between tumor cells and peritumor cells. This observation further suggested that the molecular signaling cascades could have been changed between peritumor cells and tumor cells.
To further confirm the association of LEF-1 and HBsAg, expression pattern of LEF-1 in 13 HBsAg positive HCC tissues was analyzed and compared to that in 17 HBsAg negative HCC tissues. The expression of LEF-1 was found closely associated with the HBsAg expression in HBsAg positive HCC tissues. However no significant differences were observed either in LEF-1 protein or LEF-1 isoforms when compared between tumor cells and peritumor cells in these HBsAg negative tissues. The different expression patterns of LEF-1 between HBsAg positive and negative HCC tissues suggested that HBsAg could play important roles in regulating
Wnt signaling pathway, thus providing new insights into the involvement of HBsAg in hepatocarcinogenesis. However, the molecular mechanisms of HBsAg-LEF-1 interaction and their roles in the development of HCC merit further investigation. Other viral or cellular factors might also be involved in the interaction between HBV and
Wnt pathway. For instance, HBx has been reported to be essential for the activation of Wnt/b-catenin signalling in hepatoma cells [
33], and reduced the phosphorylation level of b-catenin by suppressing GSK-3b function through the Erk pathway [
34].
Cyclin D1 and
c-myc are key regulatory genes in the control of cell cycle and cell proliferation, and thus are the best-known candidates among the LEF-1 regulated genes [
35,
36]. Over-expression of
cyclin D1 ranged from 5.6% to 54% of HCCs and was associated with advanced clinicopathological stage [
30]. Up-regulation of
c-myc gene was reported by Kawate et al in 33% of HCCs by differential PCR analysis [
37]. However, to date, the roles of
cyclin D1 and
c-myc in HCCs are still not well defined. In this study, expression of
cyclin D1 and
c-myc was markedly increased in HCC tissues, compared with normal liver tissues but the expression levels of these two genes were higher in peritumor cells than that of tumor cells. This could partly be attributed to the over-expression of 38 kDa dominant negative LEF-1 isoform in tumor cells. Up-regulation of 38 kDa dominant negative isoform of LEF-1 in tumor cells could suppress rather than activate the
Wnt pathway. Therefore the downstream target genes,
cyclin D1 and
c-myc, were induced at a lower level in the tumor cells, compared to that of peritumor cells. However the complexity of
cyclin D1 and
c-myc in HBV-associated HCC tissues should be considered.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
XT carried out molecular studies, collected and analyzed the data, performed the statistical analysis and drafted the manuscript. JL carried out IHC studies. MZM and CZ carried out part of real-time PCR studies. WDF collected the samples and participated in the design of the study. YMW designed the concept of this study and approved the final manuscript. All authors read and approved the final manuscript.